Of these genes, PTK7, KLK6 and LIMCH1 have interesting links with breast cancer; PTK7 is a catalytically inactive receptor tyrosine kinase in the Wnt signalling pathway, and a PTK7 targeted antibody–drug conjugate has been shown to reduce tumour-initiating cells62. Here, NTRK1 is linked to neoplasm.